Home / Investors Information / EDAP Continues FDA Discussion on U.S. ENLIGHT Trial Protocol Read more about EDAP Continues FDA Discussion on U.S. ENLIGHT Trial Protocol EDAP Appoints U.S. Vice President of Sales and Marketing Read more about EDAP Appoints U.S. Vice President of Sales and Marketing EDAP Continues to Expand Ablatherm-HIFU Installed Base Read more about EDAP Continues to Expand Ablatherm-HIFU Installed Base EDAP Reports on FDA Panel Meeting Read more about EDAP Reports on FDA Panel Meeting EDAP Reports Third Quarter 2009 Financial Results Read more about EDAP Reports Third Quarter 2009 Financial Results EDAP Appoints Top U.S. Urologist to Lead FDA HIFU Clinical Trial Read more about EDAP Appoints Top U.S. Urologist to Lead FDA HIFU Clinical Trial EDAP Announces Webcast and Conference Call of Third Quarter 2009 Results Read more about EDAP Announces Webcast and Conference Call of Third Quarter 2009 Results EDAP Secures First U.S. Sonolith I-Sys Device Sale Read more about EDAP Secures First U.S. Sonolith I-Sys Device Sale EDAP Options Contracts to Trade on NASDAQ OMX Philadelphia Stock Exchange Read more about EDAP Options Contracts to Trade on NASDAQ OMX Philadelphia Stock Exchange EDAP to Participate in HIFU Liver Cancer Trial Read more about EDAP to Participate in HIFU Liver Cancer Trial Pagination First page « First Previous page ‹ Previous … Page 37 Page 38 Page 39 Page 40 Current page 41 Page 42 Page 43 Page 44 Page 45 … Next page Next › Last page Last » Subscribe to
EDAP Continues FDA Discussion on U.S. ENLIGHT Trial Protocol Read more about EDAP Continues FDA Discussion on U.S. ENLIGHT Trial Protocol
EDAP Appoints U.S. Vice President of Sales and Marketing Read more about EDAP Appoints U.S. Vice President of Sales and Marketing
EDAP Continues to Expand Ablatherm-HIFU Installed Base Read more about EDAP Continues to Expand Ablatherm-HIFU Installed Base
EDAP Reports Third Quarter 2009 Financial Results Read more about EDAP Reports Third Quarter 2009 Financial Results
EDAP Appoints Top U.S. Urologist to Lead FDA HIFU Clinical Trial Read more about EDAP Appoints Top U.S. Urologist to Lead FDA HIFU Clinical Trial
EDAP Announces Webcast and Conference Call of Third Quarter 2009 Results Read more about EDAP Announces Webcast and Conference Call of Third Quarter 2009 Results
EDAP Secures First U.S. Sonolith I-Sys Device Sale Read more about EDAP Secures First U.S. Sonolith I-Sys Device Sale
EDAP Options Contracts to Trade on NASDAQ OMX Philadelphia Stock Exchange Read more about EDAP Options Contracts to Trade on NASDAQ OMX Philadelphia Stock Exchange
EDAP to Participate in HIFU Liver Cancer Trial Read more about EDAP to Participate in HIFU Liver Cancer Trial
